FDA Warns Indian Drugmaker for CGMP Violations

Drug Industry Daily
A A
Vipor Chemicals drew a warning letter from the FDA for CGMP violations observed during an inspection last year at its facility in Vadodara, Gujarat — including the use of an API supplied by a manufacturer on an FDA import alert.

To View This Article:

Login

Subscribe To Drug Industry Daily